2018 MDX and RDX# Automobile - 车轮上的传奇
L*6
1 楼
阿里会不会被蜜柚爆菊啊？
今天俩IPO，以色列公司疯涨，另一个是德国公司，跌19percent，是巧合？
REWALK ROBOTICS LTD.
The Israeli company raised $36 million after offering 3 million at $12 per
share. And underwriters have a 30-day option to buy an additional 450,000
shares. The offering was below what the company previously expected. In
August, the company expected to raise as much as $53.6 million by offering 3
.35 million shares between $14 per share and $16 share. ReWalk plans to use
the cash raised to increase marketing and develop new products. Shares of
the company, which are listed on the Nasdaq stock exchange under the ticker
symbol "RWLK," soared $13.60, or 113.3 per cent, to close at $25.60.
AFFIMED THERAPEUTICS
The German biopharmaceutical company develops treatments that use the body's
immune system to fight tumour cells. It raised $56 million after offering 8
million shares at $7 per share. Underwriters have a 30-day option to buy an
additional 1.2 million shares. The offering was below what the company
previously expected. The company planned to raise as much as $81.3 million
by offering 6.25 million shares between $11 per share and $13 per share. It
plans to use the money raised fund research for cancer treatments. Shares of
the company, which are listed on the Nasdaq stock exchange under the ticker
symbol "AFMD," fell $1.30, or 18.6 per cent, to close at $5.70.
今天俩IPO，以色列公司疯涨，另一个是德国公司，跌19percent，是巧合？
REWALK ROBOTICS LTD.
The Israeli company raised $36 million after offering 3 million at $12 per
share. And underwriters have a 30-day option to buy an additional 450,000
shares. The offering was below what the company previously expected. In
August, the company expected to raise as much as $53.6 million by offering 3
.35 million shares between $14 per share and $16 share. ReWalk plans to use
the cash raised to increase marketing and develop new products. Shares of
the company, which are listed on the Nasdaq stock exchange under the ticker
symbol "RWLK," soared $13.60, or 113.3 per cent, to close at $25.60.
AFFIMED THERAPEUTICS
The German biopharmaceutical company develops treatments that use the body's
immune system to fight tumour cells. It raised $56 million after offering 8
million shares at $7 per share. Underwriters have a 30-day option to buy an
additional 1.2 million shares. The offering was below what the company
previously expected. The company planned to raise as much as $81.3 million
by offering 6.25 million shares between $11 per share and $13 per share. It
plans to use the money raised fund research for cancer treatments. Shares of
the company, which are listed on the Nasdaq stock exchange under the ticker
symbol "AFMD," fell $1.30, or 18.6 per cent, to close at $5.70.
